Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 868 results for "Novartis Company"

Deal still possible in Colombia-Novartis cancer drug talks : minister

Deal still possible in Colombia-Novartis cancer drug talks : m...

BOGOTA (Reuters) - The door remains open for Swiss pharmaceutical company Novartis to reach a deal with Colombia to lower the cost of cancer drug imatinib and prevent the Andean country from allowing generic production of the medication, the health minister ... Reuters, 1 month ago

45 images for Novartis Company

Reuters, 1 week ago
Business Insider, 1 week ago
Xconomy, 5 days ago
Channel NewsAsia, 1 week ago
Reuters UK, 1 month ago
4 Traders, 1 month ago
Reuters UK, 1 month ago, 1 month ago
Reuters, 1 month ago
World Intellectual Property Review, 1 month ago

Novartis India's AGM on July 29, 2016

Novartis India Ltd has informed BSE that the Annual General Meeting (AGM) of the Company will be held on July 29, 2016.
 Money Control4 days ago Meet Respiratory Experts from Novartis, Chiesi, MedImmune and Mylan at COPD 2016  BioPharma Dive8 hours ago Novartis India appoints Monaz Noble as additional director  Money Control2 weeks ago Novartis India appoints Sandra Martryes as additional director  Money Control2 months ago

Novartis India tumbles as buyback plan disappoints investors

after the company's buyback plan disappointed investors. The company announced its buyback plan after market hours yesterday, 26 May 2016. Meanwhile, the S BSE Sensex was up 181.32 points or 0.69% at 26,550.90. More than usual volumes were witnessed on the ...
 Business Standard1 month ago FDA nod for Strides Shasuns HIV drug and other top pharma news  India Infoline1 month ago Novartis India gallops as board to consider buyback  Business Standard1 month ago Novartis India advances 15% on buyback buzz  Money Control1 month ago

Novartis shares slide 13 pc after Q4 results

today slumped 13 per cent on disappointment over the company's earnings for the quarter ended March 2016. The stock tumbled 13 per cent to Rs 720 on BSE. Novartis India yesterday reported a standalone net profit of Rs 21.5 crore for the March quarter. It had ...
 Business Standard1 month ago

Sun Pharma gains nearly 3% as company buys 14 brands from Novartis

This acquisition marks Sun Pharma's foray into the Japanese prescription market and provides us an opportunity to build a larger product portfolio in the future. Mumbai : Shares of Sun Pharma rose by nearly 3 per cent on March 30 as the drug major forayed ...
 Asian Age2 months ago
Reuters UK

Novartis Africa Day

On December 5th, Novartis senior executives gathered in Basel, Switzerland for the first-ever , to review the company's innovative work in Africa, including growing commercial activity, novel approaches to expand access to high-quality, affordable ...
 Hospital Pharmacy Europe2 days ago Novartis' Sandoz aims for 5 biosim launches by 2020  FiercePharma1 week ago Novartis aims to nearly triple biosimilar drugs on market by 2020  Sharenet1 week ago CORRECTED (OFFICIAL)-Novartis aims to nearly triple biosimilar drugs on market by 2020  Yahoo! Finance1 week ago
Share Market Updates

3,200 Shares in Novartis AG (NVS) Acquired by BlackRock Institutional Trust Company N.A.

BlackRock Institutional Trust Company N.A. bought a new position in Novartis AG (NYSE:NVS) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 3,200 shares of the ...
 Ticker Report6 days ago Quadrature Capital Ltd Invests $11,550,000 in Novartis AG (NVS)  Mideast Time3 days ago HC Stocks Reports: Pernix Therapeutics Holdings Inc (NASDAQ:PTX), Novartis AG (ADR) (NYSE:NVS)  Share Market Updates4 days ago Bank of Nova Scotia Trust Co. Purchases New Stake in Novartis AG (NVS)  Mideast Time4 days ago

Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases

There is no shortage of companies out there trying to tweak our immune systems in one way or another to treat diseases like cancer. Today, IFM Therapeutics, a new startup seeded by Boston firm Atlas Venture, has joined the fray. IFM, a startup in ...
 Xconomy5 days ago IFM Therapeutics raises USD27m Series A Financing led by Atlas Venture and Abingworth  Private Equity Wire4 days ago IFM Therapeutics bags $27 mln Series A  ACQ Magazine5 days ago Cambridge Upstart Banks $27 Million from Investors Like Novartis AG and Atlas Venture  BioSpace5 days ago

Sandoz plans to launch five major global biosimilars by 2020

Sandoz, a Novartis company, announced plans to launch five major oncology and immunology biologic biosimilars by 2020, according to a recent press release. The announcement indicates efforts of maximizing patient access to these biosimilar ...
 Healio3 days ago Novartis aims to launch five major global biosimilars by 2020  Pharmafile6 days ago Sandoz Plans to Launch Five Biosimilars by 2020  BioPharm International5 days ago Doubling down on biosimilars, Novartis plans five launches by 2020  BioPharma Dive1 week ago

Novartis to Triple Biosimilar Offering by 2020

• Comments Off on Swiss-based pharmaceutical company Novartis aims increase its number of biosimilar drugs on the market by 2020. Source: Healthcare Packaging: News, trends and analysis of pharmaceuticals, biologics, medical devices,
 Converter News5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less